Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study

Philippe Cabre (1) , M. Mejdoubi (2) , S. Jeannin (1) , H. Merle (3) , Y. Plumelle (4) , G. Cavillon (5) , D. Smadja (1) , R. Marignier (5)

1 Department of Neurology, Pierre Zobda-Quitman University Hospital, Fort de France
2 Department of Radiology, Pierre Zobda-Quitman University Hospital, Fort de France
3 Department of Ophthalmology, Pierre Zobda-Quitman University Hospital, Fort de France
4 Department of Biological Hematology, Pierre Zobda-Quitman University Hospital, Fort de France
5 Department of Neurology, Pierre-Wertheimer Hospital, Civilian Hospices of Lyon, Lyon

Domains: Life Sciences [q-bio]; Human health and pathology

Philippe Cabre, M. Mejdoubi, S. Jeannin, H. Merle, Y. Plumelle, et al.. Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study. Journal of Neurology, 2018, 265 (4), pp.917-925. ⟨10.1007/s00415-018-8771-5⟩. ⟨hal-03540910⟩